Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Blood Flow Restriction Training in Tennis Elbow (elbow)

18. juli 2026 oppdatert av: SAMİ KÜÇÜKŞEN, Necmettin Erbakan University

Effects of Blood Flow Restriction Training on Pain, Function, Disability, Quality of Life, and Common Extensor Tendon Thickness and Echogenicity in Patients With Lateral Epicondylitis: A Prospective Randomized Controlled Trial

Lateral epicondylitis (LE) is a common musculoskeletal disorder caused by repetitive overuse of the forearm extensor muscles. It is characterized by pain over the lateral epicondyle of the humerus, which may radiate to the surrounding tissues at the origin of the wrist extensor tendons. LE is one of the most frequent causes of lateral elbow pain, with a reported prevalence of approximately 1-3% in the general population.

Among conservative interventions, exercise-based rehabilitation is considered a cornerstone of management. In particular, exercise programs incorporating eccentric contractions have demonstrated superior clinical outcomes compared with several other exercise approaches and are therefore widely recommended.

Blood flow restriction training (BFRT) has recently emerged as an alternative rehabilitation strategy that promotes neuromuscular adaptations while using low mechanical loads. BFRT involves the application of a pneumatic cuff, tourniquet, or elastic band around the proximal portion of an extremity to partially restrict arterial inflow while substantially reducing venous return, thereby creating localized metabolic and hemodynamic stress during exercise.

The primary aim of this randomized controlled trial was to investigate the effects of BFRT on pain, functional status, pain-free grip strength, health-related quality of life, and ultrasonographic characteristics of the common extensor tendon in patients with lateral epicondylitis.

Studieoversikt

Detaljert beskrivelse

Lateral epicondylitis (LE) is a common musculoskeletal disorder caused by repetitive overuse of the forearm extensor muscles. It is characterized by pain over the lateral epicondyle of the humerus, which may radiate to the surrounding tissues at the origin of the wrist extensor tendons. LE is one of the most frequent causes of lateral elbow pain, with a reported prevalence of approximately 1-3% in the general population. Although numerous conservative and invasive treatment modalities have been described, no universally accepted treatment algorithm currently exists. Among conservative interventions, exercise-based rehabilitation is considered a cornerstone of management because it improves tendon load tolerance, increases muscle strength, and facilitates functional recovery.

Although no consensus has been reached regarding the optimal exercise protocol, recent research has focused on interventions that enhance the adaptation of the common extensor tendon to mechanical loading. In particular, exercise programs incorporating eccentric contractions have demonstrated superior clinical outcomes compared with several other exercise approaches and are therefore widely recommended. Furthermore, regular exercise has been shown to improve tendon mechanical properties by increasing collagen synthesis as well as collagen fiber number and diameter.

To achieve meaningful improvements in muscle strength and hypertrophy, resistance exercise is generally recommended at loads of at least 70% of the one-repetition maximum (1RM). However, such loading is often poorly tolerated by individuals experiencing pain, muscle weakness, or muscle atrophy during the early stages of musculoskeletal rehabilitation. Consequently, high-intensity resistance exercise may exacerbate symptoms and reduce treatment adherence.

Blood flow restriction training (BFRT) has recently emerged as an alternative rehabilitation strategy that promotes neuromuscular adaptations while using low mechanical loads. BFRT involves the application of a pneumatic cuff, tourniquet, or elastic band around the proximal portion of an extremity to partially restrict arterial inflow while substantially reducing venous return, thereby creating localized metabolic and hemodynamic stress during exercise.

In BFRT, resistance exercises are typically performed at 20-30% of the one-repetition maximum (1RM). Despite the low training intensity, accumulating evidence indicates that BFRT can produce gains in muscle strength and hypertrophy comparable to those achieved with conventional high-intensity resistance training.

These characteristics make BFRT an attractive adjunct or alternative to traditional resistance exercise in musculoskeletal rehabilitation, particularly for minimizing excessive tissue loading during tendon healing, preventing muscle atrophy, and preserving functional capacity. Nevertheless, evidence regarding the effects of BFRT on clinical outcomes and tendon morphology in patients with lateral epicondylitis remains limited.

The primary aim of this randomized controlled trial was to investigate the effects of BFRT on pain, functional status, pain-free grip strength, health-related quality of life, and ultrasonographic characteristics of the common extensor tendon in patients with lateral epicondylitis. A secondary aim was to compare these outcomes with those achieved using a conventional exercise program and to determine whether BFRT induces measurable structural changes in tendon morphology as assessed by ultrasonography.

Studietype

Intervensjonell

Registrering (Faktiske)

60

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Konya, Tyrkia (Türkiye)
        • Necmettin Erbakan University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • age between 18 and 75 years;
  • clinical diagnosis of lateral epicondylitis based on medical history and physical examination;
  • pain intensity of ≥4 on a 10-cm Visual Analog Scale (VAS) during daily activities;
  • provision of written informed consent.

Exclusion Criteria:

  • hypertension, diabetes mellitus, cardiovascular disease, peripheral vascular disease, previous deep vein thrombosis, or lymphedema;
  • orthopedic, rheumatologic, or neurological disorders affecting the upper extremity;
  • fibromyalgia;
  • congenital or acquired elbow deformity;
  • previous trauma, fracture, or surgery involving the affected upper extremity;
  • cervical radiculopathy or peripheral neuropathy affecting the involved limb;
  • receipt of any treatment for lateral epicondylitis within the preceding 3 months;
  • skin lesions, infection, or open wounds at the cuff application site;
  • bleeding disorders or current anticoagulant therapy;
  • pregnancy;
  • active malignancy or a history of malignancy;
  • cognitive impairment or neurological or psychiatric disorders that could interfere with comprehension of study procedures or completion of outcome assessments.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Blood flow restriction training (BFRT) group
The exercise program in this group was performed under blood flow restriction using a pneumatic cuff positioned around the proximal portion of the affected upper arm.

Both groups participated in a supervised exercise program consisting of 12 sessions over four weeks (three sessions per week), with each session lasting approximately 45 minutes. Each treatment session began with 3-5 minutes of transverse friction massage applied to the painful region, followed by gentle circular soft-tissue mobilization in a proximal-to-distal direction. Resistance exercises were then performed using dumbbells and consisted of concentric and eccentric wrist extension and forearm supination exercises. The order of exercises was standardized for all participants throughout the intervention period.

Participants allocated to the BFRT group performed the exercise program under blood flow restriction using a pneumatic cuff positioned around the proximal portion of the affected upper arm. Before the intervention, arterial occlusion pressure (AOP) was individually determined for each participant. The cuff pressure used during training was set at 50% of the individual AOP. Tot

Aktiv komparator: Control group
Participants in the control group performed the same exercise protocol without blood flow restriction.
Participants in the control group performed the identical exercise protocol without blood flow restriction.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Patient-Rated Tennis Elbow Evaluation (PRTEE)
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a disease-specific, patient-reported outcome measure designed to assess pain and functional disability associated with lateral epicondylitis (14,15). The questionnaire consists of two domains evaluating pain and functional limitations, with a total score ranging from 0 to 100, where higher scores indicate greater pain and disability. The Turkish version of the PRTEE has demonstrated satisfactory validity and reliability
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Visual Analog Scale (VAS)
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Pain intensity at rest and during activity was assessed using a 10-cm Visual Analog Scale (VAS). The scale ranges from 0 ("no pain") to 10 ("worst imaginable pain"). Participants were instructed to indicate the intensity of their pain by marking a point on the scale corresponding to their perceived pain level. The score was determined by measuring the distance (cm) from the left endpoint to the participant's mark. The VAS is a valid and reliable instrument for assessing pain intensity in patients with musculoskeletal disorders.
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Pain-free grip strength (PFGS) Assessment
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
PFGS is considered a sensitive indicator of functional impairment in patients with lateral epicondylitis. Participants were seated with the shoulder in a neutral position, the elbow comfortably extended, and the forearm pronated. Firstly, maximal grip strength was measured using a Jamar hydraulic hand dynamometer in kilograms on the unaffected side. Participants were then instructed to gradually squeeze the dynamometer with the affected hand and stop immediately when pain was first perceived. Three measurements were obtained for each assessment with a 20-second rest interval between trials, and the mean value was used for analysis. PFGS was calculated as the ratio of pain-free grip strength of the affected side to maximal grip strength of the unaffected side. This method has been shown to provide excellent reliability in individuals with lateral epicondylitis.
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Health-Related Quality of Life
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Health-related quality of life was evaluated using the 36-Item Short Form Health Survey (SF-36). The SF-36 comprises eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better health-related quality of life. The Turkish version of the SF-36 has been validated and shown to be reliable
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Ultrasonographic Evaluation of the Common Extensor Tendon
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).

Ultrasonographic examinations were performed using a 7-12 MHz linear-array transducer (Logiq P8; GE Healthcare, Wisconsin, USA). The measurements were taken by a researcher with four years of experience in musculoskeletal ultrasound who did not know which group the patients belonged to.

Participants were examined in a seated position with the elbow flexed to 90° and the forearm pronated. Longitudinal images of the common extensor tendon were obtained, and tendon thickness perpendicular to the tendon fibers, was measured at two standardized anatomical landmarks: (1) the deepest point over the capitellum and (2) the midpoint of the radiocapitellar joint. To improve measurement reliability, each measurement was repeated three times, and the mean value was used for statistical analyses.

Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studieleder: SAMİ KÜÇÜKŞEN, Professor, Necmettin Erbakan University, Faculty of Medicine

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

28. februar 2025

Primær fullføring (Faktiske)

28. februar 2026

Studiet fullført (Faktiske)

28. februar 2026

Datoer for studieregistrering

Først innsendt

14. juli 2026

Først innsendt som oppfylte QC-kriteriene

14. juli 2026

Først lagt ut (Faktiske)

17. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

21. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. juli 2026

Sist bekreftet

1. mai 2025

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

All collected IPD, all IPD that underlie results in a publication

IPD-delingstidsramme

Starting 6 months after publication- ending 2 years after the publication of results

Tilgangskriterier for IPD-deling

Journal editors or reviewers may request this information from the corresponding author's email address if they deem it necessary.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL
  • SEVJE
  • ICF
  • ANALYTIC_CODE
  • CSR

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere